Olympio Metals Limited (ASX:OLY) (Olympio or the Company) is pleased to announce that it has…
Category:
Investing
-
-
-
Investing
Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study…
-
-
-
-
-
-
-